Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study
Compose a Response to This Article
Other responses
No responses have been published for this article.
